F
Futura Surgicare
Manufacturer of surgical sutures and wound closure devices
About Futura Surgicare
Futura Surgicare Pvt Ltd is a medical technology company headquartered in Bengaluru, India, that manufactures and exports surgical sutures and other wound closure products. The company was founded in 1994 by A.D. Setty, who has over 40 years of experience in the pharmaceutical and surgical device industries. Other founders include Shyamala Devi and Dronachala Setty. The company's vision is to be the primary choice for surgeons seeking safe and secure wound closure solutions. The company's business model is centered on manufacturing and distributing a wide range of surgical consumables to healthcare professionals and hospitals. Its flagship brand, Dolphin Sutures, was launched in 2003 and includes a comprehensive portfolio of absorbable and non-absorbable sutures. Futura Surgicare was a pioneer in the Indian market, being the first to introduce synthetic absorbable sutures like Polyglycolic Acid (PGA) and Polyglactin 910 (PGLA), as well as Triclosan-coated antibacterial sutures. Beyond sutures, the product line has expanded to include hernia meshes (Dolphin Mesh), skin staplers (Dolphin Stapler), surgical tapes, and bone wax. The company serves clients such as medical colleges, multi-specialty hospitals, and government institutions. Futura Surgicare exports its products to over 85 countries across Asia, Europe, Africa, and Australia. Futura Surgicare operates a manufacturing facility in Bangalore that adheres to Good Manufacturing Practices and holds certifications including CE, ISO 13485, and WHO-GMP. The facility is equipped with a Class 10,000 manufacturing area and in-house sterilization capabilities. In June 2024, the company secured a $25 million Series B investment from Jashvik Capital. This funding is intended to support the development of new devices, drive both organic and inorganic growth, and improve access to affordable medical products in India and international markets.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 128
- Open positions
- None listed
- Dealroom signal
- 44.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Surgery, Surgical Equipment, wound care, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Apr 2026
- Capital deployed
- $0
- Preferred round
- EARLY VC
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2024 | $25M | $100M | Undisclosed | — |
Growth signals
Latest recorded traffic for Futura Surgicare is 450 monthly website visits, down 91% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Futura Surgicare in the Bengaluru ecosystem
The Futura Surgicare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Futura Surgicare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Futura Surgicare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









